|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1995-8-28
|
|
pubmed:abstractText |
1. A new pyrrolidine derivative (levetiracetam), resembling piracetam, was given as antiepileptic concomitant drug to patients with chronic epilepsy. 2. In a single-blind add-on rising-dose study the cognitive side-effects were investigated twice after one week of administration. 3. The results did not show any significant changes in cognitive performances.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0278-5846
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
411-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7624492-Administration, Oral,
pubmed-meshheading:7624492-Adult,
pubmed-meshheading:7624492-Anticonvulsants,
pubmed-meshheading:7624492-Cognition,
pubmed-meshheading:7624492-Drug Therapy, Combination,
pubmed-meshheading:7624492-Epilepsy,
pubmed-meshheading:7624492-Female,
pubmed-meshheading:7624492-Humans,
pubmed-meshheading:7624492-Male,
pubmed-meshheading:7624492-Memory,
pubmed-meshheading:7624492-Middle Aged,
pubmed-meshheading:7624492-Neuropsychological Tests,
pubmed-meshheading:7624492-Piracetam,
pubmed-meshheading:7624492-Psychiatric Status Rating Scales,
pubmed-meshheading:7624492-Reaction Time
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.
|
|
pubmed:affiliation |
Epilepsy centre, Heemstede, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
